AGER and type 2 diabetes mellitus: HMGB1 can signal through receptor for advanced glycation end products (RAGE) and Toll-like receptors (TLRs) to activate nuclear factor-κB (NF-κB) signaling pathway [5, 6] thus contributing to the inflammatory responses in T2D.